162 related articles for article (PubMed ID: 37406859)
1. Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells.
Ravindran A; Dasari S; Ruan GJ; Artymiuk CJ; He R; Viswanatha DS; Abeykoon JP; Zanwar S; Young JR; Goyal G; Go RS; Rech KL;
Mod Pathol; 2023 Oct; 36(10):100268. PubMed ID: 37406859
[TBL] [Abstract][Full Text] [Related]
2. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.
Pileri SA; Grogan TM; Harris NL; Banks P; Campo E; Chan JK; Favera RD; Delsol G; De Wolf-Peeters C; Falini B; Gascoyne RD; Gaulard P; Gatter KC; Isaacson PG; Jaffe ES; Kluin P; Knowles DM; Mason DY; Mori S; Müller-Hermelink HK; Piris MA; Ralfkiaer E; Stein H; Su IJ; Warnke RA; Weiss LM
Histopathology; 2002 Jul; 41(1):1-29. PubMed ID: 12121233
[TBL] [Abstract][Full Text] [Related]
3. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
4. Rosai-Dorfman Disease Displays a Unique Monocyte-Macrophage Phenotype Characterized by Expression of OCT2.
Ravindran A; Goyal G; Go RS; Rech KL;
Am J Surg Pathol; 2021 Jan; 45(1):35-44. PubMed ID: 33177341
[TBL] [Abstract][Full Text] [Related]
5. Histiocytosis and Neoplasms of Macrophage-Dendritic Cell Lineages: Multimodality Imaging with Emphasis on PET/CT.
Huynh KN; Nguyen BD
Radiographics; 2021; 41(2):576-594. PubMed ID: 33606566
[TBL] [Abstract][Full Text] [Related]
6. Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases.
O'Malley DP; Duong A; Barry TS; Chen S; Hibbard MK; Ferry JA; Hasserjian RP; Thompson MA; Richardson MS; Jaffe R; Sidhu JS; Banks PM
Mod Pathol; 2010 Dec; 23(12):1616-23. PubMed ID: 20729813
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders.
Lau SK; Chu PG; Weiss LM
Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 Expression and Molecular Genetic Findings in Periocular Histiocytoses and Neoplasms of Macrophage-Dendritic Cell Lineage.
Milman T; Eiger-Moscovich M; Henry RK; Ida CM; Ruben M; Shields CL; Lally SE; Penne RB; Stefanyszyn MA; Bilyk JR; Rapuano CJ; Rabinowitz M; Eagle RC
Am J Ophthalmol; 2022 Oct; 242():36-51. PubMed ID: 35594918
[TBL] [Abstract][Full Text] [Related]
9. How I Diagnose Rosai-Dorfman Disease.
Ravindran A; Rech KL
Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous histiocytoses in children.
Fraitag S; Emile JF
Histopathology; 2022 Jan; 80(1):196-215. PubMed ID: 34958507
[TBL] [Abstract][Full Text] [Related]
11. Histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Comparison of recent WHO classification published 2017 and classification of Histiocyte Society published 2016.
Král Z; Adam Z; Ježová M; Pour L; Krejčí M
Vnitr Lek; 2020; 66(6):19-27. PubMed ID: 33380149
[TBL] [Abstract][Full Text] [Related]
12. Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations.
Luder CM; Nordmann TM; Ramelyte E; Mühleisen B; Kerl K; Guenova E; Dummer R
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):926-934. PubMed ID: 29341328
[TBL] [Abstract][Full Text] [Related]
13. Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin.
Satpathy AT; Brown RA; Gomulia E; Briseño CG; Mumbach MR; Pan Z; Murphy KM; Natkunam Y; Chang HY; Kim J
Mod Pathol; 2018 Sep; 31(9):1479-1486. PubMed ID: 29743654
[TBL] [Abstract][Full Text] [Related]
14. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].
Bösmüller H; Nann D; Horger M; Fend F
Pathologe; 2015 Sep; 36(5):458-66. PubMed ID: 26305142
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
[TBL] [Abstract][Full Text] [Related]
16. Challenges in the Histopathologic Diagnosis of Histiocytic Neoplasms.
Rech KL; He R
J Natl Compr Canc Netw; 2021 Nov; 19(11):1305-1311. PubMed ID: 34781270
[TBL] [Abstract][Full Text] [Related]
17. Monocyte/macrophage system and malignancies.
Schmidt D
Med Pediatr Oncol; 1994; 23(5):444-51. PubMed ID: 8084313
[TBL] [Abstract][Full Text] [Related]
18. PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours.
Ungureanu IA; Cohen-Aubart F; Héritier S; Haroche J; Donadieu J; Emile JF
Histopathology; 2023 Aug; 83(2):320-325. PubMed ID: 37012662
[TBL] [Abstract][Full Text] [Related]
19. Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis.
Hsu SM; Ho YS; Hsu PL
Am J Pathol; 1991 Jun; 138(6):1389-404. PubMed ID: 1647137
[TBL] [Abstract][Full Text] [Related]
20. Histiocytic disorders.
McClain KL; Bigenwald C; Collin M; Haroche J; Marsh RA; Merad M; Picarsic J; Ribeiro KB; Allen CE
Nat Rev Dis Primers; 2021 Oct; 7(1):73. PubMed ID: 34620874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
